NO2018022I1 - Letermovir, eller dets salt, solvat eller solvat av dets salt - Google Patents

Letermovir, eller dets salt, solvat eller solvat av dets salt

Info

Publication number: NO2018022I1
Authority: NO; Norway
Prior art keywords: solvate; salt; letermovir
Prior art date: 2003-05-02

Application number

NO2018022C

Other languages

English (en)

Original Assignee

Aicuris Anti Infective Cures Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2018-07-04

Publication date

2018-07-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33305099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2018022(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-07-04 Application filed by Aicuris Anti Infective Cures Gmbh filed Critical Aicuris Anti Infective Cures Gmbh

2018-07-04 Publication of NO2018022I1 publication Critical patent/NO2018022I1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO2018022C 2003-05-02 2018-07-04 Letermovir, eller dets salt, solvat eller solvat av dets salt NO2018022I1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10319612A DE10319612A1 (de)	2003-05-02	2003-05-02	Substituierte Dihydrochinazoline
PCT/EP2004/004103 WO2004096778A1 (de)	2003-05-02	2004-04-17	Substituierte dihydrochinazoline mit antiviralen eigenschaften

Publications (1)

Publication Number	Publication Date
NO2018022I1 true NO2018022I1 (no)	2018-07-04

Family

ID=33305099

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20055649A NO333265B3 (no)	2003-05-02	2005-11-30	Substituerte dihydrokinazoliner, fremgangsmåte for fremstilling derav, anvendelse av en slik forbindelse samt medikament inneholdende denne.
NO2018022C NO2018022I1 (no)	2003-05-02	2018-07-04	Letermovir, eller dets salt, solvat eller solvat av dets salt

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20055649A NO333265B3 (no)	2003-05-02	2005-11-30	Substituerte dihydrokinazoliner, fremgangsmåte for fremstilling derav, anvendelse av en slik forbindelse samt medikament inneholdende denne.

Country Status (38)

Country	Link
US (4)	US7196086B2 (no)
EP (1)	EP1622880B3 (no)
JP (1)	JP4733631B2 (no)
KR (1)	KR100927063B1 (no)
CN (1)	CN100393706C (no)
AR (1)	AR044078A1 (no)
AT (1)	ATE355280T1 (no)
AU (1)	AU2004233978B2 (no)
BR (1)	BRPI0410029B8 (no)
CA (1)	CA2524069C (no)
CL (1)	CL2004000930A1 (no)
CO (1)	CO5700764A2 (no)
CY (2)	CY1106476T1 (no)
DE (2)	DE10319612A1 (no)
DK (1)	DK1622880T6 (no)
EC (1)	ECSP056138A (no)
EG (1)	EG25273A (no)
ES (1)	ES2284007T7 (no)
FR (1)	FR18C1029I2 (no)
HN (1)	HN2004000146A (no)
HU (2)	HUS1800018I1 (no)
IL (1)	IL171513A (no)
MA (1)	MA27794A1 (no)
MX (1)	MXPA05011707A (no)
MY (1)	MY144616A (no)
NL (1)	NL300933I2 (no)
NO (2)	NO333265B3 (no)
NZ (1)	NZ543317A (no)
PE (1)	PE20050145A1 (no)
PL (1)	PL1622880T6 (no)
PT (1)	PT1622880E (no)
RU (1)	RU2360912C2 (no)
SI (1)	SI1622880T1 (no)
TW (1)	TWI335912B (no)
UA (1)	UA82519C2 (no)
UY (1)	UY28294A1 (no)
WO (1)	WO2004096778A1 (no)
ZA (1)	ZA200508710B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de)	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
DE102005027517A1 (de)	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
DE102011101446A1 (de)	2011-05-10	2012-11-15	Aicuris Gmbh & Co. Kg	Herstellung von "Dense Bodies" (DB)
DE102012101680A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
NZ715387A (en) *	2013-06-19	2018-02-23	Aicuris Anti Infective Cures Gmbh	Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
US9890128B2 (en)	2013-12-12	2018-02-13	Merck Sharp & Dohme Corp.	Process for making substituted quinazoline compounds
US10392353B2 (en) *	2015-11-24	2019-08-27	Merck Sharp & Dohme Corp.	Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
JP6951418B2 (ja) *	2016-08-08	2021-10-20	メッドシャインディスカバリーインコーポレイテッド	抗ｈｃｍｖウイルス化合物
AU2019218150B2 (en) *	2018-02-08	2021-05-13	Phaeno Therapeutics Co., Ltd.	Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor
EP3527209A1 (en) *	2018-02-16	2019-08-21	UCB Biopharma SPRL	Pharmaceutical 6,5 heterobicyclic ring derivatives
KR102672512B1 (ko)	2018-09-12	2024-06-10	노파르티스 아게	항바이러스 피리도피라진디온 화합물
US11667613B2 (en)	2019-09-26	2023-06-06	Novartis Ag	Antiviral pyrazolopyridinone compounds
UY39095A (es)	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2- [(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio
AR121439A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método para producir una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato
UY39099A (es)	2020-02-27	2021-08-31	Aic246 Gmbh & Co Kg	2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio y composiciones farmacéuticas del mismo
AR121437A1 (es) *	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acético
AR121440A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método de preparación de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio monohidrato, dicho compuesto y el uso del mismo para el tratamiento de infecciones virales
EP3906929A1 (en)	2020-05-08	2021-11-10	AiCuris GmbH & Co. KG	Letermovir for use in the prevention and the treatment of coronavirus infections
US20230312485A1 (en)	2020-08-17	2023-10-05	Lupin Limited	A precipitation process for amorphous letermovir
CN115403528B (zh) *	2021-05-27	2025-01-07	南京正大天晴制药有限公司	无定形3,4-二氢喹唑啉衍生物的制备方法
CN114031560B (zh) *	2021-11-16	2022-10-04	山东诚创蓝海医药科技有限公司	一种来特莫韦钠盐的制备方法
UY40078A (es)	2021-12-21	2023-06-30	Aic246 Ag & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin
CN118974026A (zh) *	2022-04-01	2024-11-15	上海迪赛诺化学制药有限公司	莱特莫韦中间体及其制备方法
CN115322157B (zh) *	2022-06-02	2023-12-05	浙江车头制药股份有限公司	来特莫韦中间体化合物及其制备方法和应用
CN117229223A (zh) *	2022-06-08	2023-12-15	苏州远智医药科技有限公司	一种杂环衍生物及其药物组合物、应用
WO2025133248A1 (en)	2023-12-21	2025-06-26	Aic246 Ag & Co. Kg	Diastereomeric aminoalcohol and aminoether salts of 2-[(4r,s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl]acetic acid and their use for enantiomeric separation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320347A1 (de)	1993-06-19	1994-12-22	Boehringer Mannheim Gmbh	Quinazolin-Derivate und diese enthaltende Arzneimittel
US5854245A (en) *	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19802437A1 (de)	1998-01-23	1999-07-29	Bayer Ag	Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
US6200977B1 (en)	1998-02-17	2001-03-13	Tularik Inc.	Pyrimidine derivatives
KR20010113820A (ko)	1999-04-19	2001-12-28	시오노 요시히코	옥사디아졸 고리를 갖는 술폰아미드 유도체
DE19930075A1 (de)	1999-06-30	2001-01-04	Bayer Ag	Neue Amino- und Amidosulfonamide als antivirale Mittel
US6730682B2 (en) *	2000-07-12	2004-05-04	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
DK1325008T3 (da) *	2000-07-31	2006-02-13	Hoffmann La Roche	Piperazinderivater
EP1201765A3 (en) *	2000-10-16	2003-08-27	Axxima Pharmaceuticals Aktiengesellschaft	Cellular kinases involved in cytomegalovirus infection and their inhibition
ES2252455T3 (es)	2001-04-19	2006-05-16	Bayer Healthcare Ag	Arilsulfonamidas como agentes antivirales.
DE10138578A1 (de)	2001-08-06	2003-02-27	Bayer Ag	Heterocyclylarylsulfonamide
DE10251914A1 (de) *	2002-11-08	2004-05-19	Bayer Ag	Substituierte Chinazoline
DE10319612A1 (de) *	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de)	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
KR100610731B1 (ko) *	2004-02-24	2006-08-09	한국과학기술연구원	Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
JP5139083B2 (ja) *	2005-01-25	2013-02-06	プロレキシーズファーマシューティカルズインコーポレイテッド	抗腫瘍剤としてのキノキサリン誘導体
DE102005027517A1 (de) *	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
JP4880684B2 (ja) *	2005-07-21	2012-02-22	エフ．ホフマン−ラロシュアーゲー	Ｐｔｐ１ｂ阻害剤としてのピリド［２，３−ｄ］ピリミジン−２，４−ジアミン化合物
DE102006009928A1 (de)	2006-03-03	2007-09-06	Aicuris Gmbh & Co. Kg	Substituierte Arylsulfonamide
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
NZ715387A (en) *	2013-06-19	2018-02-23	Aicuris Anti Infective Cures Gmbh	Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration

2003
- 2003-05-02 DE DE10319612A patent/DE10319612A1/de not_active Withdrawn
2004
- 2004-04-17 AU AU2004233978A patent/AU2004233978B2/en active Active
- 2004-04-17 KR KR1020057020720A patent/KR100927063B1/ko not_active Expired - Lifetime
- 2004-04-17 CA CA2524069A patent/CA2524069C/en not_active Expired - Lifetime
- 2004-04-17 ES ES04728119.1T patent/ES2284007T7/es active Active
- 2004-04-17 DE DE502004003052T patent/DE502004003052D1/de not_active Expired - Lifetime
- 2004-04-17 AT AT04728119T patent/ATE355280T1/de active
- 2004-04-17 SI SI200430301T patent/SI1622880T1/sl unknown
- 2004-04-17 EP EP04728119.1A patent/EP1622880B3/de not_active Expired - Lifetime
- 2004-04-17 BR BRPI0410029A patent/BRPI0410029B8/pt not_active IP Right Cessation
- 2004-04-17 DK DK04728119.1T patent/DK1622880T6/da active
- 2004-04-17 NZ NZ543317A patent/NZ543317A/en not_active IP Right Cessation
- 2004-04-17 PL PL04728119T patent/PL1622880T6/pl unknown
- 2004-04-17 CN CNB2004800119284A patent/CN100393706C/zh not_active Expired - Lifetime
- 2004-04-17 MX MXPA05011707A patent/MXPA05011707A/es active IP Right Grant
- 2004-04-17 PT PT04728119T patent/PT1622880E/pt unknown
- 2004-04-17 UA UAA200511418A patent/UA82519C2/uk unknown
- 2004-04-17 WO PCT/EP2004/004103 patent/WO2004096778A1/de not_active Ceased
- 2004-04-17 RU RU2005137276/04A patent/RU2360912C2/ru active
- 2004-04-17 JP JP2006505178A patent/JP4733631B2/ja not_active Expired - Lifetime
- 2004-04-23 AR ARP040101391A patent/AR044078A1/es active IP Right Grant
- 2004-04-26 US US10/832,109 patent/US7196086B2/en not_active Ceased
- 2004-04-28 UY UY28294A patent/UY28294A1/es not_active IP Right Cessation
- 2004-04-29 HN HN2004000146A patent/HN2004000146A/es unknown
- 2004-04-29 MY MYPI20041603A patent/MY144616A/en unknown
- 2004-04-30 PE PE2004000432A patent/PE20050145A1/es active IP Right Grant
- 2004-04-30 CL CL200400930A patent/CL2004000930A1/es unknown
- 2004-04-30 TW TW093112100A patent/TWI335912B/zh active
2005
- 2005-10-20 IL IL171513A patent/IL171513A/en active IP Right Grant
- 2005-10-27 ZA ZA2005/08710A patent/ZA200508710B/en unknown
- 2005-10-29 EG EGNA2005000688 patent/EG25273A/xx active
- 2005-11-01 EC EC2005006138A patent/ECSP056138A/es unknown
- 2005-11-02 CO CO05111848A patent/CO5700764A2/es active IP Right Grant
- 2005-11-08 MA MA28581A patent/MA27794A1/fr unknown
- 2005-11-30 NO NO20055649A patent/NO333265B3/no active Protection Beyond IP Right Term
2007
- 2007-03-26 US US11/728,896 patent/US8513255B2/en active Active
- 2007-05-25 CY CY20071100709T patent/CY1106476T1/el unknown
2015
- 2015-04-09 US US14/682,512 patent/USRE46791E1/en active Active
2018
- 2018-04-17 NL NL300933C patent/NL300933I2/nl unknown
- 2018-04-21 HU HUS1800018C patent/HUS1800018I1/hu unknown
- 2018-06-15 HU HUS1800028C patent/HUS1800028I1/hu unknown
- 2018-06-29 CY CY2018019C patent/CY2018019I1/el unknown
- 2018-07-04 NO NO2018022C patent/NO2018022I1/no unknown
- 2018-07-06 FR FR18C1029C patent/FR18C1029I2/fr active Active
2020
- 2020-07-21 US US16/934,363 patent/USRE49698E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO20055649L (no)	2006-01-31
US20070191387A1 (en)	2007-08-16
BRPI0410029B1 (pt)	2019-12-31
CO5700764A2 (es)	2006-11-30
CY1106476T1 (el)	2012-01-25
CL2004000930A1 (es)	2005-03-18
MA27794A1 (fr)	2006-03-01
NO333265B3 (no)	2019-06-03
CY2018019I2 (el)	2018-12-12
USRE49698E1 (en)	2023-10-17
CN1784390A (zh)	2006-06-07
MXPA05011707A (es)	2006-02-13
BRPI0410029A (pt)	2006-04-25
TW200510343A (en)	2005-03-16
KR20060009883A (ko)	2006-02-01
CN100393706C (zh)	2008-06-11
BRPI0410029B8 (pt)	2021-06-15
ECSP056138A (es)	2006-04-19
JP4733631B2 (ja)	2011-07-27
NL300933I2 (nl)	2018-04-26
DK1622880T3 (da)	2007-06-25
KR100927063B1 (ko)	2009-11-13
HUS1800028I1 (hu)	2018-07-30
ATE355280T1 (de)	2006-03-15
JP2006525249A (ja)	2006-11-09
HK1092463A1 (zh)	2007-02-09
USRE46791E1 (en)	2018-04-17
RU2360912C2 (ru)	2009-07-10
DE10319612A1 (de)	2004-11-18
UA82519C2 (uk)	2008-04-25
AU2004233978B2 (en)	2010-02-11
UY28294A1 (es)	2004-11-30
ES2284007T7 (es)	2018-06-20
EP1622880B3 (de)	2018-05-23
WO2004096778A1 (de)	2004-11-11
FR18C1029I1 (no)	2018-08-17
US20050065160A1 (en)	2005-03-24
DE502004003052D1 (de)	2007-04-12
DK1622880T6 (da)	2018-06-18
EP1622880B1 (de)	2007-02-28
US7196086B2 (en)	2007-03-27
AR044078A1 (es)	2005-08-24
TWI335912B (en)	2011-01-11
FR18C1029I2 (fr)	2020-07-17
EG25273A (en)	2011-12-04
PT1622880E (pt)	2007-06-04
CY2018019I1 (el)	2018-12-12
PL1622880T6 (pl)	2018-08-31
AU2004233978A1 (en)	2004-11-11
CA2524069A1 (en)	2004-11-11
EP1622880A1 (de)	2006-02-08
PL1622880T3 (pl)	2007-08-31
NZ543317A (en)	2008-05-30
HN2004000146A (es)	2008-06-24
ES2284007T3 (es)	2007-11-01
MY144616A (en)	2011-10-14
ZA200508710B (en)	2006-12-27
RU2005137276A (ru)	2006-07-27
NO333265B1 (no)	2013-04-22
US8513255B2 (en)	2013-08-20
IL171513A (en)	2011-11-30
SI1622880T1 (sl)	2007-08-31
PE20050145A1 (es)	2005-05-22
NO20055649D0 (no)	2005-11-30
CA2524069C (en)	2011-11-08
HUS1800018I1 (hu)	2018-05-28

Publication	Publication Date	Title
NO2018022I1 (no)	2018-07-04	Letermovir, eller dets salt, solvat eller solvat av dets salt
EP1587535A4 (en)	2010-02-24	N-cyclohexylaminocarbonyl-benzenesulfonamide derivatives
EP1663113A4 (en)	2007-06-13	SUBSTITUTED SULFONAMIDE
DE602004003733D1 (de)	2007-02-01	Kühlschrank
DK1684731T3 (da)	2012-10-15	Filmdannende stivelsesholdig sammensætning
DK1682493T3 (da)	2009-04-20	Amidoacetonitrilderivater
NO20043346L (no)	2005-02-14	Rorspinner
DK1606277T3 (da)	2008-08-18	Imidazol-4-yl-ethynyl-pyridinderivater
NO20055787D0 (no)	2005-12-06	Varmevekslerkjern
IS8180A (is)	2005-12-14	Nýjar besímídasólafleiður
NO20054762D0 (no)	2005-10-17	Polymorphs of aripiprazole
ITMI20041561A1 (it)	2004-10-30	Frigorifero
DK1682129T3 (da)	2007-06-11	N-thiazol-2-ylbenzamidderivater
EP1650874A4 (en)	2006-07-26	Viterbi decoder
DK1636288T3 (da)	2012-04-02	Tværbindende vandige polyurethandispersioner
DE602004018858D1 (de)	2009-02-26	Emulsionszusammensetzung
DE60305435D1 (de)	2006-06-29	Cockpittür
ATE380557T1 (de)	2007-12-15	E. coli vakzin zur protektion von geflügel gegen colibazillose
IS8045A (is)	2005-09-26	Púrín-6-ón-afleiður
DK1633719T3 (da)	2010-01-04	Substituerede spirobenzazepiner
DE602004027577D1 (de)	2010-07-22	Hubschrauber
ITMI20030346A1 (it)	2004-08-28	Procedimento per la produzione di mesitilene.
ITMI20031994A1 (it)	2005-04-16	Procedimento per la preparazione di fludarabina fosfato
SE0400713L (sv)	2004-09-25	Universalfäste
DE10349030B4 (de)	2005-10-20	Axialverstellvorrichtung